ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,480Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 337

$419K Total Retail Price of All Prescriptions

Rank: 97 out of 337

195 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 195 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 195 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,428 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 399 338 1 1
WARFARIN SODIUM 324 307 2 11
METOPROLOL TARTRATE 256 241 3 6
LISINOPRIL 223 169 4 2
AMLODIPINE BESYLATE 215 209 5 3
TRAZODONE HCL 211 186 6 16
FUROSEMIDE 184 171 7 8
METFORMIN HCL 165 109 8 12
MIRTAZAPINE 160 159 9 27
CLOZAPINE 155 155 10 94
DONEPEZIL HCL 154 147 11 22
LEVOTHYROXINE SODIUM 147 121 12 5
OMEPRAZOLE 138 99 13 4
SERTRALINE HCL 128 113 14 18
ATENOLOL 126 104 15 10
HYDROCODONE-ACETAMINOPHEN 122 92 S3 16 13
BISOPROLOL FUMARATE 117 71 17 67
NAMENDA 111 111 18 35
QUETIAPINE FUMARATE 99 88 19 61
TRAMADOL HCL 86 86 20 32
CLOPIDOGREL 86 79 20 42
SYNTHROID 83 46 22 41
HYDROCHLOROTHIAZIDE 81 66 23 9
LACTULOSE 80 66 24 105
LANTUS 73 67 25 49
GABAPENTIN 71 61 26 20
ALENDRONATE SODIUM 68 68 27 19
POLYETHYLENE GLYCOL 3350 64 48 28 47
TAMSULOSIN HCL 64 34 28 25
CITALOPRAM HBR 63 61 30 17
RAMIPRIL 61 47 31 80
ATORVASTATIN CALCIUM 60 56 32 7
ENALAPRIL MALEATE 60 60 32 37
OLANZAPINE 60 60 32 108
DIOVAN 59 59 35 26
OXYBUTYNIN CHLORIDE ER 58 46 36 124
HUMALOG 55 54 37 153
DIVALPROEX SODIUM 51 51 38 101
GLYBURIDE 51 39 R 38 53
CARBIDOPA-LEVODOPA 51 51 38 92
GLIPIZIDE 50 46 41 45
RANITIDINE HCL 50 37 41 30
SEROQUEL 50 40 41 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 16, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.